Stolmár & Partner, ARNOLD RUESS and Meyerlustenberger Lachenal are happy to invite you to our annual Pharma- and Life Sciences days on 21 and 22 June 2018 in the Jewish Cultural Center in Munich.
As every year, high-calibre in-house practitioners and attorneys will present recent trends and topics in Pharma and Life Sciences which they encounter during their daily work, fresh from their desks. Our speakers are inter alia from Novartis International AG, Merck KGaA, Creoptix AG, Stalicla S.A., NTD Intellectual Property Attorneys, Beijing, the European Patent Office and IP Nexus.
You will hear more about the impact of the EU Incentive Review on Export and Manufacturing Waivers in Supplementary Protection Certificates and Paediatric Extensions, recent Pharma case law in the EPO and in China, the challenges in creating a start-up in orphan drugs for Autism Spectrum Disorders (ASD), new technologies for Drug Discovery and new trends in commercialization of life sciences patents on specialized IP platforms.
Our Pharmadays are a unique opportunity to discuss in a relaxed environment with your peers from industry the most recent trends and topics in pharma and life sciences.
We are pleased that the well-known Dusseldorf IP law firm Arnold Ruess supports the 2018 Pharmadays.
We are pleased that the well-known Swiss IP law firm Meyerlustenberger-Lachenal supports the Pharmadays 2018.